Johan Strömqvist
Director/Board Member at NEWBURY PHARMACEUTICALS AB
Profile
Johan Strömqvist is the founder of Single Technologies AB, where he holds the titles of President & Director since 2014.
He is currently an Independent Director at Newbury Pharmaceuticals AB since 2020.
Dr. Strömqvist has a graduate degree from the University of Stockholm and graduate and doctorate degrees from the Royal Institute of Technology.
Johan Strömqvist active positions
| Companies | Position | Start |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Director/Board Member | 31/12/2019 |
Single Technologies AB
 Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Founder | 31/12/2013 |
Training of Johan Strömqvist
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Private companies | 1 |
|---|---|
Single Technologies AB
Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Commercial Services |
- Stock Market
- Insiders
- Johan Strömqvist
